M10.47
Other secondary gout, ankle and foot
Clinical Classification Guidelines
Medical Intelligence & Overview
Other secondary gout affecting the ankle and foot (ICD-10 code M10.47) is a form of gout that develops as a result of an underlying condition. Unlike primary gout, which occurs due to genetic or metabolic issues, secondary gout arises because of other health problems or the use of certain medications. It typically causes episodes of pain, swelling, and redness in the affected joints, especially in the ankles and feet. Recognizing this condition early can lead to better management and relief of symptoms.
Causes & Symptoms
Clinical Causes: Chronic kidney disease impairing uric acid excretion Use of medications such as diuretics or aspirin Metabolic disorders like obesity or insulin resistance Certain blood disorders such as leukemia Alcohol abuse, which increases uric acid production Other health conditions that affect how the body processes uric acid
Key Symptoms: Sudden episodes of intense joint pain, often at night Swelling and tenderness in the affected ankle or foot Redness and warmth over the joint Limited joint mobility during gout attacks Persistent discomfort between attacks Tophi, or deposits of uric acid crystals, may form in chronic cases
Diagnostic & Treatment
Diagnosis Path: The diagnosis of other secondary gout involves a combination of clinical assessment and laboratory tests. A healthcare provider will review symptoms, medical history, and possibly perform joint aspiration to extract fluid for analysis. The presence of uric acid crystals under the microscope confirms gout. Blood tests measuring uric acid levels can support the diagnosis but are not definitive, as uric acid levels may vary. Imaging tests like X-rays or ultrasound can reveal joint damage or crystal deposits.
Treatment Protocols: Managing other secondary gout comprises both addressing the underlying health issue and controlling gout symptoms. Treatment strategies include: - **Medications:** Nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, or colchicine to reduce inflammation during flare-ups. - **Urate-lowering therapies:** Such as allopurinol or febuxostat, to decrease uric acid levels and prevent future attacks. - **Lifestyle modifications:** Dietary adjustments to reduce purine intake (e.g., limiting red meat, seafood, alcohol), maintaining a healthy weight, staying well-hydrated, and managing comorbid conditions. - **Addressing underlying causes:** Improving kidney function, managing metabolic disorders, or altering medication regimens that contribute to increased uric acid production. Following medical advice and regular monitoring can help lessen the frequency of gout episodes and prevent joint damage.
Clinical Advice & FAQs
Billing Guidance
Is M10.47 a billable ICD-10 code?
Yes, M10.47 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M10.47?
Clinical documentation must specify the nature of Other secondary gout, ankle and foot and any associated comorbidities for accurate reporting.
Cite this Clinical Reference